Nosocomial or Hospital-acquired Infections: An Overview

Disease-a-Month

Volumn 55, Issue 7, 2009, Pages 422-438

  McFee, Robin B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN DERIVATIVE; FLUCONAZOLE; METICILLIN; NAFCILLIN; OXACILLIN;

ANTIBIOTIC RESISTANCE; AVIAN INFLUENZA; CAUSE OF DEATH; CLOSTRIDIUM DIFFICILE; COST BENEFIT ANALYSIS; ENVIRONMENTAL SANITATION; HAND WASHING; HEALTH CARE COST; HEALTH EDUCATION; HIGH RISK POPULATION; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RATE; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; MYCOSIS; PUBLIC HEALTH; REVIEW; RISK FACTOR; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS;

CAUSE OF DEATH; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HUMANS; INFECTION CONTROL; RISK FACTORS; UNITED STATES;

EID: 67149119447     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.disamonth.2009.03.014     Document Type: Review

References (76)

1. Klevens R.M., Edwards J.R., and Richards C.L. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Pub Health Rep 122 (2007) 160-166 March-April
2. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Cont 32 (2004) 470-485
3. CDC, and NNIS system. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992-June 2003. Issued August 2003. Am J Infect Cont 31 (2003) 481-498
4. Edwards J.R., Peterson K.D., Andrus M.L., et al. National Healthcare Safety Network (NHSN) Report. Data summary for 2006, issued 2007. Am J Infect Cont 35 (2007) 290-301
5. Centers for Disease Control and Prevention (CDC). Outline for health care-associated infection surveillance. http://www.cdc.gov/ncidod/dhqp/nhsn+documents.html
6. Centers for Disease Control and Prevention (CDC). Reduction in central line associated bloodstream infection among patients in intensive care units-Pennsylvania. April 2001-March 2005. MMWR Morb Wkly Rep 54 (2005) 1013-1016
7. Institute for healthcare improvement. Saving 100,000 lives campaign. http://www.ihi.org
8. Association for Professionals in Infection Control and epidemiology (APIC). Government advocacy. http://www.apic.org/content/navigationmenu/governmentadvocacy/mandatoryreporting/abouttheissue/about_the_issue.htm
9. Tokars J.I., Richards C., Andrus M., et al. The changing face of surveillance for health care associated infections. Clin Infect Dis 39 (2004) 1347-1352
10. American Hospital Association, Hospital Statistics 2004 (2005), Chicago Health Forum LLC
11. Burke J.P. Infection control-A problem for patient safety. N Engl J Med 348 (2004) 651-656
12. Carey A.J., Saiman L., and Polin R.A. Hospital Acquired Infections in the NICU: Epidemiology for the new millennium. Clin Perinatol 35 (2008) 223-249
13. National nosocomial infections surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Cont 32 (2004) 470-485
14. Nguyen Q.V. Hospital Acquired Infections (2007). http://www.emedicine.com/ped/fulltopic/topic1619.htm August
15. Jarvis W.R. Infection control and changing health care delivery systems. Emerg Infect Dis 7 2 (2001) 170-173
16. Fauci A.S. Infectious diseases: Considerations for the 21st century. Clin Infect Dis 32 (2001) 675-685
17. Trends in causes of death among the elderly. Aging Trends 1(March) 2001. Publication of the Centers for Disease Control and Prevention. Atlanta, Georgia. National Center for Health Statistics.
18. Wenzel R.P. Edmond, MB. Team based prevention of catheter related infections. N Engl J Med 355 (2006) 2781-2783
19. Kyne L. Health care associated costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 34 (2002) 346-353
20. Goldmann D.A. Epidemiology and prevention of pediatric viral respiratory infections in health care institutions. Emerg Infect Dis 7 (2001) 249-253
21. Summary of notifiable diseases-United States, 2002. MMWR Morb Mortal Wkly Rep 51 (2004) 1-84
22. Deaths: Leading causes for 2001. Natl Vital Stat Rep 52 (2003) Table E
23. Scheurer D.B., Hicks L.S., Cook E.F., et al. Short report-Accuracy of ICD-9 coding for Clostridium difficile infections: A retrospective cohort. Epidemiol Infect 135 (2007) 1010-1013
24. McFee R.B. Avian influenza: The next pandemic?. Dis Mon 53 (2007) 337-388
25. 2001. Population Reference Bureau, editor. United States Government. NCHS-FASTATS-Leading Causes of Death Deaths-Leading Causes. (Data are for US for year indicated). Number of deaths for leading causes of death. http://www.cdc.gov/nchs/fastats/lcod.htm.
26. O'Connor. diff-Rise in UK deaths. 72% increase between 2005 and 2006. JC. FEBS Lett (2008) 28. http://patient-health-education.suite101.com/article.cfm/c_difficile_rise_in_uk_deaths http://patient-health-education.suite101.com/article.cfm/c_difficile_rise_in_uk_deaths Last accessed 6/24/08
27. Christensen M., and Jepsen O.B. Reduced rates of hospital acquired UTI in medical patients. Prevalence surveys indicated effect of active infection control programmes. J Hosp Infect 47 (2001) 36-40
28. Sands K., Vineyard G., and Platt R. Surgical site infections occurring after hospital discharge. J Infect Dis 173 (1996) 963-970
29. Manian F., and Meyer L. Adjunctive use of monthly physician questionnaires for surveillance of surgical site infections after hospital discharge and in ambulatory surgical patients: Report of a seven year experience. Am J Infect Cont 25 (1997) 390-394
30. Zerey M., Paton B.L., Lincourt A.E., et al. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt) 8 6 (2007) 557-566
31. Deaths involving MRSA and Clostridium difficile continue to rise. Health statistics. Quarterly Spring (2007) 22. http://www.statistics.gov.uk/releases Issued by the Office on National Statistics: Lond SW;1V:2QQ. http://www.statistics.gov.uk/releases
32. Griffin F.A. Reducing methicillin-resistant Staphylococcus aureus (MRSA) infections. Jt Comm J Qual Patient Safety/JCAHO 33 12 (2007) 726-731
33. Fordtran J.S. Colitis due to Clostridium difficile toxins: Underdiagnosed, highly virulent, and nosocomial. Proc Bayl Univ Med Cent 19 (2006) 3-12
34. Dramatic rise in C diff deaths. BBC News (2008) 34. http://news.bbc.co.uk/1/hi/health/7268578.stm February 28, http://news.bbc.co.uk/1/hi/health/7268578.stm. Last accessed 8/12/08
35. Sunenshine R.H., and McDonald L.C. Clostridium difficile-associated disease: New challenges from an established pathogen. Cleve Clin J Med 73 2 (2006) 187-197
36. Friedenberg F.K. Clostridium difficile associated disease: Changing epidemiology and treatment options. Medscape gastroenterology 36. http://www.medscape.com/viewarticle/563386_print Last accessed 6/25/08
37. Ashu N.J., Tompkins D., and Wilcox M.H. Comparative analysis of prevalence, risk factors and molecular epidemiology of antibiotic associated diarrhea due to Clostridium difficile, Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol 44 (2006) 2785-2791
38. Kuijper E.J., and Coignard T.P. Emergence of Clostridium difficile associated disease in North America and Europe. Clin Microbiol Infect 12 Suppl 6 (2006) 2-18
39. McDonald L.C., Kilgore G.E., Thomson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
40. Best practices document for the management of Clostridium difficile in all health care settings. Provincial Infectious Diseases Advisory Committee (PIDAC). Ministry of Health and Long Term Care. Published December 2004, Revised, November 2007.
41. Isada C.M., and Kasten B.L. Clostridium difficile. Infectious Diseases Handbook. 5th ed. (2003), Lexi-Comp, Hudson, OH 83-86
42. Johal S.S., Hammond J., Solomon K., et al. Clostridium difficile associated diarrhea in hospitalized patients: Onset in the community and hospital and role of flexible sigmoidoscopy. Gut 53 (2004) 673-677
43. Halsey J. Current and future treatment modalities for Clostridium difficile associated disease. Am J Health Syst Pharm 65 (2008) 705-715
44. Drudy D., Harnedy N., Fanning S., et al. Emergence and control of fluoroquinolone resistant, toxin A negative, toxin B positive Clostridium difficile. Infect Cont Hosp Epidemiol 28 8 (2007) 932-940
45. Kim J., Smathers S.A., Prasad P., et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 122 (2008) 1266-1270
46. Eriksen H.M., Iversen B.G., and Aavitsland P. Prevalence of nosocomial infections in hospitals in Norway, 2002 and 2003. J Hosp Infect 60 (2005) 40-45
47. Klavs J., Bufon Luznik T., Skerl M., et al. Prevalence of and risk factors for hospital-acquired infections in Slovenia-Results of the first national survey, 2001. J Hosp Infect 54 (2003) 149-157
48. Starakis J., Marangos M., Gikas A., et al. Repeated point prevalence survey of nosocomial infections in a Greek University Hospital. J Chemother 14 (2002) 272-278
49. Dunn P.M., and Semmelweis I. Of Budapest and the prevention of puerperal fever. Arch Dis Child Fetal Neonatal Ed 90 4 (2005) F345-F348
50. Taisuke H., and Kawaoka Y. Influenza: Lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3 (2005) 591-600
51. Centers for Disease Control and Prevention. Deaths-Leading causes. http://www.cdc.gov/nchs/fastats/lcod.htm Accessed May 28, 2006
52. Zigmund J. No more room; overcrowding blamed for ambulance diversions http://Modernhealthcare.com. Available at: http://www.modernhealthcare.com/printwindow.cms?articleId=38689&pageType=article.
53. Guideline for hand hygiene in Health Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. A report of the CDC. Morb Mortal Wkly Rep 51 (2002) RR-16
54. Langmuir A.D. Changing concepts of airborne infection of acute contagious diseases: A reconsideration of classic epidemiologic theories. Ann NY Acad Sci 353 (1980) 35-44
55. McFee R.B. Preparing for an era of weapons of mass destruction (WMD): Are we there yet?. Why we should all be concerned. Part I. Vet Human Toxicol 44 (2002) 193-199
56. Smith S.M. Where have you been?. The potential to overlook imported disease in the acute setting. Eur J Emerg Med 12 (2005) 230-233
57. Madren L.K., Shipman Jr. C., and Hayden F.G. In vitro inhibitory effects of combinations of anti-influenza agents. Antivir Chem Chemother 6 (1995) 109-113 2005;12:230-3
58. Aronson N.E., Sanders J.W., and Moran K.A. In harm's way: Infections in deployed American military Forces. Clin Infect Dis 43 (2006) 1045-1051
59. Centers for Disease Control and Prevention. Acinetobacter baumanii infections among patients at military medical facilities treating injured US service members 2002-2004. MMWR Morb Mortal Wkly Rep 53 (2004) 1063-1066
60. Joint Commission Accreditation Healthcare Organizations. http://www.jointcommission.org/
61. Cunningham R., and Dial S. Is over use of proton pump inhibitors fueling the current epidemic of Clostridium difficile associated diarrhea?. J Hosp Infect 70 (2008) 1-6
62. Aseeri M., Schroeder T., Kramer J., et al. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile associated diarrhea in hospitalized patients. Am J Gastroenterol 103 (2008) 2308-2313
63. Akhtar A.J., and Shaheen M. Increasing incidence of Clostridium difficile associated diarrhea in African American and Hispanic patients: Association with the use of proton pump inhibitor therapy. J Natl Med Assoc 99 (2007) 500-504
64. Creedon S.A. Healthcare workers' hand decontamination practices: Compliance with recommended guidelines. J Adv Nurs 51 (2005) 208-216
65. Boyce J.M. Hand hygiene compliance monitoring: Current perspectives from the USA. J Hosp Infect 70 Suppl 1 (2008) 2-7
66. Cohen M.B. Clostridium difficile infections: emerging epidemiology and new treatments. J Pediatr Gastroenterol Nutr 48 Suppl 2 (2009) S63-S65
67. Yuen K.Y., and Wong S.S.Y. Human infection by avian influenza A H5N1. Hong Kong Med J 11 (2005) 189-199
68. Beigel J.H., Farrar J., Han A.M., et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 353 (2005) 1374-1385
69. US Department of Health and Human Services. http://www.pandemicflu.gov/vaccine
70. World Health Organization, WHO. Interim guidelines on clinical management of humans infected by influenza A (H5N1). http://www.who.int/csr/disease/avian_influenza/guidelines/Guidelines_Clinical%20Management_H5N1_rev.pdf
71. McFee R.B. Gulf War servicemen and servicewomen: The long road home and the role of health care professionals to enhance the troop's health and healing. Dis Mon 54 (2008) 257-336
72. Centers for Disease Control and Prevention. Overview of drug resistant acinetobacter infections in healthcare settings. http://www.cdc.gov/ncidod/dhqp/ar_acinetobacter.html Released September 24, 2004
73. Frattarelli D.A., Reed M.D., Giacoia G.P., et al. Antifungals in systemic neonatal candidiasis. Drugs 64 (2004) 949-968
74. Manzoni P., Stolfi I., Pugni L., et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 356 (2007) 2483-2495
75. Kaufman D., Boyle R., Hazen K.C., et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 345 (2001) 1660-1666
76. Moss L. Hospital C difficile deaths: The patients let down by those they trusted. http://news.scotsman.com/latestnews/-Hospital-c-difficile-deaths.4370831.jp Accessed August 12, 2008